Monday, April 4, 2011

Google Alert - treating lung cancer

Web7 new results for treating lung cancer
 
CyberKnife::Active Clinical Studies(2)
Lung. Treating inoperable early stage lung cancer with the CyberKnife System. Study information listed on www.clinicaltrials.gov identifier: NCT00643318 ...
www.cyberknife.com/active-clinical-studies/index.aspx
Synta Announces Results Presented at AACR Further Elucidate ...
This represents an entirely novel approach to treating cancer, ... resistance to cisplatin -- a common first-line treatment of lung cancer -- leads to high ...
www.smartmoney.com/news/pr/?story=pr-20110404...1
What Is Breast Cancer and just how could you cure It ...
CMF chemotherapy is a kind of treatment that is used for treating breast cancer. This therapy is very much effective in giving a good result to a patient of ...
chemotherapylungcancer.wordpress.com/.../what-is-breast-can...
Patient | Mesothelioma News
Mesothelioma is the name given to the cancer affecting the lining surrounding the internal ... a once-daily pill for treating lung and pancreatic cancer ...
mesotheliomanewsdigest.com/tag/patient/
4 cancer-treatment drugs make best-seller list | floridatoday.com ...
19), both drugs for treating lung cancer, according to the survey. The best- seller... Full Article at China Post. The Daily Reveille logo ...
sec.floridatoday.com/article/07YXaHkadW1Xg?q=Breast...
Paclitaxel
Aoct , plant extract haorui Advanced cancer , lung cancer breast Paclitaxel ... derived from the latest attempt to treat breast lung Microtubule growth ...
bauhaus.edu.mx/archivos_zip/enlinea/mod/lesson/paclitaxel
Reportlinker Adds Drug Delivery in Cancer - technologies, markets ...
Colorado Cyberknife VSI Treatment for Lung Cancer and Pulmonary Tumors .... treating brain cancer through ultra-keyhole surgery ...
article.wn.com/.../Reportlinker_Adds_Drug_Delivery_in_Canc...


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment